Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 735659, 5 pages
http://dx.doi.org/10.1155/2014/735659
Research Article

Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia

1Department of Neurology, Faculty of Medicine in Pilsen, Charles University in Prague, Husova 3, 301 66 Pilsen, Czech Republic
2Faculty Hospital in Pilsen, Alej Svobody 80, 304 60 Pilsen, Czech Republic
3Department of Histology and Embryology and Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Husova 3, 301 66 Pilsen, Czech Republic
4Department of Biology, Faculty of Medicine in Pilsen, Charles University in Prague, Husova 3, 301 66 Pilsen, Czech Republic
5Central Immunoanalytical Laboratory, Faculty Hospital in Pilsen, Dr. E. Benese 13, 305 99 Pilsen, Czech Republic

Received 30 September 2013; Accepted 18 December 2013; Published 9 January 2014

Academic Editor: Franco M. Buonaguro

Copyright © 2014 J. Polivka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

J. Polivka, J. Polivka Jr., V. Rohan, et al., “Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia,” BioMed Research International, vol. 2014, Article ID 735659, 5 pages, 2014. https://doi.org/10.1155/2014/735659.